Use of multiple biomarkers to improve the prediction of death from cardiovascular causes  by Zethelius, B. et al.
the occurrence of clinically evident cerebral hyperperfusion. Crossed cere-
bellar hypoperfusion (CCH) is a reduction in blood flow in the cerebellar
hemisphere contralateral to a supertentorial lesion. This phenomenon can be
seen after CEA. The authors sought to clarify the significance of postoper-
ative CCH in patients with cerebral hyperperfusion using SPECT scanning
and tests of cognitive impairment.
Brain perfusion was measured using SPECT scanning before and
immediately after CEA and on postoperative day 3 in 80 patients who
underwent CEA for70% stenosis. Postoperative CCH was determined by
differences between asymmetry of perfusion in the cerebellar hemispheres
before and after CEA. Patients also underwent neuropsychologic testing
preoperatively and at 1 month after CEA.
The authors used a definition of a 100% increase in cerebral blood flow
for cerebral hyperperfusion and found that it had developed in 11 of 80
patients after CEA. SPECT scans were performed immediately after CEA
and on postoperative day 3. Of the 11 patients in whom cerebral hyperper-
fusion developed, CCHwas observed in seven on postoperative day 3. Three
patients had cerebral hyperperfusion syndrome and exhibited cerebral hy-
perperfusion and CCH on postoperative day 3, and postoperative cognitive
impairment developed. Four of eight patients with asymptomatic cerebral
hyperperfusion exhibited CCH. Three of these patients exhibited postoper-
ative cognitive impairment. The four patients with asymptomatic cerebral
hyperperfusion who did not have CCH did not experience postoperative
cognitive impairment.
Comment: Cerebral hyperperfusion after CEA is more complicated than
most are aware. The article points out that it occurs more frequently than is
generally thought, has different patterns of hyperperfusion, and can result, at
least when measured using sophisticated neuropsychiatric testing, in cognitive
impairment even in the absence of clinical hyperperfusion syndrome.
Use of multiple biomarkers to improve the prediction of death from
cardiovascular causes
Zethelius B, Berglund L, Sundstrom J, et al. N Engl J Med 2008;358:
2107-16.
Conclusion: In elderly men, use of biomarkers of cardiovascular and
renal abnormalities increases risk stratification for death from cardiovascular
causes beyond that of a predictive model using traditional risk factors only.
Summary: The authors sought to evaluate the utility of multiple
biomarkers from different disease pathways to predict the risk of death from
cardiovascular causes in elderly men. Data were acquired from the Uppsala
Longitudinal Study of AdultMen (ULSAM). This community-based cohort
study was initiated in 1970 of 50-year-old men born from 1920 to 1924 and
living in Uppsala, Sweden. This analysis is based on the third examination cycle
of this cohort when participants were approximately 71 years of age (1991 to
1995). Established risk factors for cardiovascular disease analyzed included age,
systolic blood pressure, use or nonuse of antihypertensive treatment, total
cholesterol levels, high-density lipoprotein cholesterol, use or nonuse of lipid-
lowering treatment, presence or absence of diabetes, smoking status, and body
mass index. Additional biomarkers evaluated reflected those that mirrored
myocardial cell damage, left ventricular dysfunction, renal failure, and inflam-
mation (troponin I, N-terminal pro-brain natriuretic peptide, cystatin C, and
C-reactive protein). Follow-up was for a median of 10.0 years.
There were 1135 participants (mean age, 71 years at baseline). Of
these, 315 died during follow-up, and 136 of the deaths were the result of
cardiovascular disease. All the biomarkers predicted risk of death from
cardiovascular causes according to Cox proportional hazard models and
adjusting for established risk factors. The predictive value increased signifi-
cantly when the biomarkers were incorporated into a model with established
risk factors in the entire cohort and in the group of 661 patients who did not
have cardiovascular disease at baseline (C statistic with biomarkers vs with-
out biomarkers, 0.766 vs 0.664, P  .001; C statistic with biomarkers vs
without biomarkers, 0.748 vs 0.688, P  .03).
Comment: Previous studies evaluating the combination of multiple
biomarkers in predicting cardiovascular risk (N Engl J Med 2006;355:
2631-9) have not shown as dramatic results as the current study. The
authors point out that this may be because participants in the present study
were an average of 10 years older than the participants in previous studies,
and that the combination of biomarkers used in the current study were not
used in previous studies. Biomarkers used in this study may identify patients
with functional or structural abnormalities of their cardiovascular systems
that have not yet led to overt cardiovascular disease but place the patients at
risk for the development of cardiovascular disease during follow-up.
Risk of new aneurysms after surgery for popliteal aneurysm
Ravn A, Wanhainen A, Bjorck M. Br J Surg 2008;95:571-5.
Conclusion: In patients treated surgically for popliteal artery aneu-
rysm, the development of new aneurysms at other sites during follow-up is
common.
Summary: Patients with popliteal artery aneurysms (PAA) are known
to have a high incidence of concurrent aneurysmal degeneration of the
opposite popliteal artery or the abdominal aorta, or both, at the time of
discovery of the index PAA. The risk of developing new aneurysms in
previously apparently normal arterial segments after PAA repair is, however,
unknown. This study sought to determine the incidence of development of
new aneurysms in previously nonaneurysmal popliteal arterial segments after
repair of an index PAA. The study was based on analysis of the Swedish
Vascular Registry. (Every citizen in Sweden has a unique personal identity
code that can be used in vascular surgical research.)
Between 1987 and 2002, 571 patients (717 legs) in Sweden had a
primary operation for PAA. Analysis for this study began in January 2005.
Data were crosschecked against the national population registry and indi-
cated 337 patients had undergone PAA repair during the study period and
were alive in January 2005. Patients were then assessed for the presence of
additional aneurysms at the time of their index PAA repair and were asked to
participate in a telephone interview and a re-examination. Of these, 240
patients agreed, and 190 were re-examined by ultrasonography at a medium
of 7 years (range, 2.9-18.7 years) after their index PAA repair.
At the time of the PAA repair, the number of patients with at least one
aneurysm, in addition to the index PAA, was 108 (56.8%) at the index
operation, and 131 (68.0%) at re-examination. The number of additional
aneurysms increased from 244 to 346 (an increase of 41.8%). Among the 82
patients who had an isolated PAA at the index operation, a new aneurysm
was detected in 23 at the time of their follow-up ultrasound study.
Patients in whom new aneurysms developed tended to be older (P 
.004). The presence of bilateral PAA at the index operation was associ-
ated with a later development of an abdominal aortic aneurysm (P 
.004). Increased age and hypertension at the time of the index operation
were associated with multianeurysmal disease at any time (P  .004 and
P  .012 respectively).
Venous bypass grafts were used to treat 138 of the legs, and six (4.3%)
developed aneurysm degeneration of the venous bypass graft. Within 3 years
of the initial PAA repair, no normal arterial segments had developed suffi-
cient aneurysmal degeneration that required surgery. Overall, an additional
102 aneurysms developed in 74 patients, and only 59 of the 190 subjects
re-examined did not develop an additional aneurysm.
Comment: This study indicates new aneurysm development in
patients with PAA is frequent. Because no patient developed a new aneurysm
that required surgery 3 years of the index operation, it would seem that a
practical plan for follow-up would be to reinvestigate patients with PAAs for
new aneurysms every 3 years, beginning 3 years after the initial popliteal
aneurysm repair.
Do current outcomes justify more liberal use of revascularization for
vasculogenic claudication? A single-center experience of 1000 consec-
utively treated limbs
Taylor SM, Kalbaugh CA, Healy NG, et al. J Am Coll Surg 2008;206:
1053-64.
Conclusions: In contemporary practice, treatment of claudication is
safe, effective, and predominantly endovascular.
Summary: This is a retrospective review of 1000 limbs in 669 patients
treated for what was determined to be medically refractory vasculogenic
claudication. The authors assess procedural complication rates, patency of
reconstructions, maintenance of ambulatory status, maintenance of inde-
pendent living, survival, symptom resolution, symptom recurrence, and limb
salvage. Of the 1000 limbs treated, aortoiliac disease was treated in 70.1%
and infrainguinal occlusive disease in 29.9%. Endovascular therapy was used
in 64.3% of the limbs treated and open surgery in 35.7%. The 30-day
complication rate was 7.5%. The authors noted no difference in complica-
tion rates comparing types of treatment or level of disease. At 1 and 5 years,
reconstruction primary patency was 87.7% and 70.8%, secondary patency
was 97.8% and 93.9%, survival was 94.4% and 76.9%, and limb salvage was
100% and 98.8%, respectively. Symptom resolution occurred in 78.8% and
recurrence in 18.1%. There was slightly higher resolution and recurrence
noted in patients treated with endovascular therapy.
Comment: You have to admire the fact that this group of surgeons
keeps track of what they do and tries to report their results. Unfortunately,
the way they report their results is not all that useful. Patients were not
stratified by degree of claudication, TransAtlantic Inter-Society Consensus
lesions, prehemodynamic and posthemodynamic status, or the occurrence of
single-level or multilevel disease. We also have no idea about who was not
treated. Nevertheless, it does appear that if you are willing to spend a lot of
money, you can treat a lot of patients with claudication and you won’t hurt
many of them very much.
Fistula elevation procedure: Experience with 295 consecutive cases
during a 7-year period
Bronder CM, Cull DL, Kuper SG, et al. J AmColl Surg 2008;206:1076-82.
Conclusion: Elevation of an autogenous fistula that is otherwise too
deep or tortuous for access is a valuable adjunct that improves ultimate
utilization of autogenous arteriovenous fistulas in hemodialysis access.
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